Abstract/References
Prediction of the prognosis of somatoform disorders using the Minnesota Multiphasic Personality Inventory
Akiko Sato, Shuntaro Itagaki, Takatomo Matsumto, Yoko Ise, Shunya Yokokura, Tomohiro Wada, Kaoru Hayashi, Takeyasu Kakamu, Tetsuhito Fukushima, Takuya Nikaido, Shinichi Konno, Hirooki Yabe
Author information
- Akiko Sato
Department of Neuro Psychiatry, Fukushima Medical University - Shuntaro Itagaki
Department of Neuro Psychiatry, Fukushima Medical University - Takatomo Matsumto
Department of Neuro Psychiatry, Fukushima Medical University - Yoko Ise
Department of Neuro Psychiatry, Fukushima Medical University - Shunya Yokokura
Department of Neuro Psychiatry, Fukushima Medical University - Tomohiro Wada
Department of Neuro Psychiatry, Fukushima Medical University - Kaoru Hayashi
Department of Neuro Psychiatry, Fukushima Medical University - Takeyasu Kakamu
Department of Hygiene and Preventive Medicine, Fukushima Medical University - Tetsuhito Fukushima
Department of Hygiene and Preventive Medicine, Fukushima Medical University - Takuya Nikaido
Department of Orthopedic Surgery, Fukushima Medical University - Shinichi Konno
Department of Orthopedic Surgery, Fukushima Medical University - Hirooki Yabe
Department of Neuro Psychiatry, Fukushima Medical University
Abstract
Background: Somatoform disorders are frequently resistant to treatment. This study aimed to determine the utility of the Minnesota Multifaceted Personality Inventory (MMPI) in predicting the prognosis of somatoform disorders.
Methods: Overall, 125 patients diagnosed with somatoform disorders between January 1, 2013 and December 31, 2017 in the psychiatric department of Fukushima Medical University Hospital were included. Patients with positive outcomes were identified based on a subjective estimation regarding (1) pain and (2) social functions, including activities of daily living. They were divided into the improved group (IG) and the non-improved group (NIG). Each factor was then descriptively compared between the two groups, and the sensitivity and specificity were determined.
Results: The NIG had significantly higher scores but only on the Hy scale. Thus, the optimal Hy scale cutoff score was calculated. The cutoff point was 73.5, with a sensitivity of 55.7% and a specificity of 71.7%.
Conclusion: An MMPI Hy scale score higher than a cutoff value of 73.5 predicts a poor response to conventional supportive psychotherapy or drug therapy in patients with somatoform disorders. This cutoff point may be used as an important index for selecting treatment for somatoform disorders.
References
- World Health Organization. ICD-10, the ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines, World Health Organization;1992.
- Okuma T. Modern Clinical Psychiatry, 12th ed. Tokyo:Kaneharashuppan, 2013.
- Watanabe K, Konno S. Musculoskeletal pain management. Prog Med, 33:9-12, 2013.
- Mashiko H. Indefinite complaints in orthopedic surgery. Japanese Journal of Clinical Psychiatry, 41:275-281, 2012.
- Mizuno Y, Fukunaga M, Nakai Y. Differences in psychological characteristics between chronic pain patients and other psychosomatic (mind-body) disease patient. The Journal of the Japanese Society for the Study of Chronic Pain, 23:193-199, 2004.
- Vendrig AA. The Minnesota Multiphasic Personality Inventory and chronic pain, a conceptual analysis of a long-standing but complicated relationship. Clin Psychol Rev, 20:533-559, 2000.
- Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology, research findings and theoretical considerations. Psychosom Med, 64:773-786, 2002.
- Garyfallos G, Adamopoulou A, Karastergiou A, et al. Somatoform disorders:comorbidity with other DSM-III-R psychiatric diagnoses in Greece. Compr Psychiatry, 40:299-307, 1999.
- Balasanyan M, Boone KB, Ermshar A, et al. Examination of the Modified Somatic Perception Questionnaire (MSPQ) in a large sample of credible and noncredible patients referred for neuropsychological testing. Clin Neuropsychol, 32:165-182, 2018.
- Koelen JA, Eurelings-Bontekoe EH, van Broeckhuysen-Kloth SA, Snellen WM, Luyten P. Social cognition and levels of personality organization in patients with somatoform disorders, a case-control study. J Nerv Ment Dis, 202:217-223, 2014.
- Vendrig AA, Derksen JJ, de Mey HR. MMPI-2 Personality Psychopathology Five (PSY-5) and prediction of treatment outcome for patients with chronic back pain. J Pers Assess, 74:423-438, 2000.
- Barnes D, Gatchel RJ, Mayer TG, Barnett J. Changes in MMPI profile levels of chronic low back pain patients following successful treatment. J Spinal Disord, 3:353-355, 1990.
- McCreary C, Naliboff B, Cohen M. A comparison of clinically and empirically derived MMPI groupings in low back pain patients. J Clin Psychol, 45:560-570, 1989.
- Williams DE, Thompson JK, Haber JD, Raczynski JM. MMPI and headache:a special focus on differential diagnosis, prediction of treatment outcome, and patient-treatment matching. Pain, 24:143-158, 1986.
- McCreary C, Turner J, Dawson E. The MMPI as a predictor of response to conservative treatment for low back pain. J Clin Psychol, 35:278-284, 1979.
- Kasahara S. Psychiatric approach for the patients with chronic pain. Japanese Journal of Clinical Psychiatry, 42:739-748, 2013.
- Nikaido T, Yabuki S, Otani K, et al. Scientific approach for pain based on biopsychosocial model: liaison approach for chronic low back pain. Journal of Musculoskeletal Pain Research, 8:192-198, 2016.
- Shioya T. History of MMPI, The Society for MMPI New Japanese Version MMPI. Tokyo: Kongoshuppan, 2004.
- Noro H, Arakawa W, Ide S. MMPI Handbook, Basics to Understand, Japanese Clinical Society for the Study of MMPI. Tokyo:Kongoshuppan, 2014.
- Butcher JN. MMPI-2 in Psychological Treatment. Oxford:Oxford University Press, 1990.
- Kanazawa University Psychology Laboratory. MMPI Japanese Language Implementation Guide (Kanazawa University version). Kanazawa: Kanazawa University Psychology Laboratory, 1965.
- Lipsker CW, Bölte S, Hirvikoski T, Lekander M, Holmström L, Wicksell RK. Prevalence of autism traits and attention-deficit hyperactivity disorder symptoms in a clinical sample of children and adolescents with chronic pain. J Pain Res, 11:2827-2836, 2018.
- Bishop-Fitzpatrick L, Minshew NJ, Eack SM. A systematic review of psychosocial interventions for adults with autism spectrum disorders. J Autism Dev Disord, 43:687-694, 2013.
- Ornduff SR, Brennan AF, Barrett CL. The Minnesota Multiphasic Personality Inventory (MMPI) Hysteria (Hy) scale:scoring bodily concern and psychological denial subscales in chronic back pain patients. J Behav Med, 11:131-146, 1988.
- Kinder BN, Curtiss G, Kalichman S. Anxiety and anger as predictors of MMPI elevations in chronic pain patients. J Pers Assess, 50:651-661, 1986.
- Aragona M, Tarsitani L, De Nitto S, Inghilleri M. DSM-IV-TR “pain disorder associated with psychological factors” as a nonhysterical form of somatization. Pain Res Manag, 13:13-18, 2008.
- McGrath RE, O’Malley WB. The assessment of denial and physical complaints:the validity of the Hy scale and associated MMPI signs. J Clin Psychol, 42:754-760, 1986.
- Tarescavage AM, Scheman J, Ben-Porath YS. Prospective comparison of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and MMPI-2-Restructured Form (MMPI-2-RF) in predicting treatment outcomes among patients with chronic low back pain. J Clin Psychol Med Settings, 25:66-79, 2018.
- van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev, CD011142, 2014.
- van Ravesteijn H. Mindfulness-based cognitive therapy for patients with somatoform disorders. Tijdschr Psychiatr, 58:198-206, 2016.
- Cyranka K, Rutkowski K, Mielimąka M, et al. Changes in personality functioning as a result of group psychotherapy with elements of individual psychotherapy in persons with neurotic and personality disorders-MMPI-2. Psychiatr Pol, 50:105-126, 2016.
- Kurlansik SL, Maffei MS. Somatic symptom disorder. Am Fam Physician, 93:49-54, 2016.
- Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med, 69:889-900, 2007.
Figures





